Related Experiment Video
Updated: Oct 10, 2025

23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
19.3K
Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
Jamshid Gadoev1, Anthony D Harries2,3, Oleksandr Korotych4
1World Health Organization Country Office in Uzbekistan, Tashkent 100100, Uzbekistan.
International Journal of Environmental Research and Public Health
|December 10, 2021
Summary
Tuberculosis (TB) remains a significant global health challenge, with 10 million new cases in 2019. Continued efforts are crucial to accelerate the slow decline in TB incidence and combat the disease effectively.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) affects millions globally, with 10 million new cases reported in 2019.
- The incidence of TB has shown a very slow decline in recent years, highlighting the persistent burden of the disease.
- Understanding the global epidemiology of TB is essential for targeted public health interventions.
Discussion:
- The slow decline in TB cases suggests that current control strategies may require enhancement.
- Addressing the multifaceted nature of TB transmission and disease progression is critical.
- Global health initiatives must adapt to overcome persistent challenges in TB eradication.
Key Insights:
- 10 million new tuberculosis cases were estimated globally in 2019.
- The rate of decline in TB cases is insufficient to meet global targets.
- Sustained and intensified global efforts are necessary to control the TB epidemic.
Outlook:
- Future research should focus on novel strategies to accelerate TB decline.
- Strengthening healthcare systems and improving access to diagnostics and treatment are vital.
- International collaboration is key to achieving global TB elimination goals.
Related Concept Videos
Pulmonary Tuberculosis V
263
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
263
Pulmonary Tuberculosis IV
226
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
226
Pulmonary Tuberculosis I
390
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
390
Pulmonary Tuberculosis II
613
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
613
Pulmonary Tuberculosis III
504
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
504
Principles of Disease Surveillance
226
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
226

